Large Cell Neuroendocrine Carcinoma of the Thymus: A Two-Case Report by Yoon, Yong Han et al.
Korean J Thorac Cardiovasc Surg 2012;45:60-64 □ Case Report □
http://dx.doi.org/10.5090/kjtcs.2012.45.1.60 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online)
− 60  −
Departments  of 
1Thoracic  and  Cardiovascular  Surgery, 
2Hematology  and  Oncology, 
3Diagnostic  Radiology, 
4Pathology,  Inha  University  Hospital, 
Inha  University  School  of  Medicine
Received:  August  12,  2011,  Revised:  November  2,  2011,  Accepted:  November  11,  2011
Corresponding  author: Kwang  Ho  Kim,  Department  of  Thoracic  and  Cardiovascular  Surgery,  Inha  University  Hospital,  Inha  University  School 
of  Medicine,  7-206  Sinheung-dong  3-ga,  Jung-gu,  Incheon  400-711,  Korea
(Tel)  82-32-890-2280  (Fax)  82-32-890-3390  (E-mail)  khkim@inha.ac.kr
 C  The  Korean  Society  for  Thoracic  and  Cardiovascular  Surgery.  2012.  All  right  reserved.
CC  This  is  an  open  access  article  distributed  under  the  terms  of  the  Creative  Commons  Attribution  Non-Commercial  License  (http://creative-
commons.org/licenses/by-nc/3.0)  which  permits  unrestricted  non-commercial  use,  distribution,  and  reproduction  in  any  medium,  provided  the 
original  work  is  properly  cited.
Large Cell Neuroendocrine Carcinoma of the Thymus: 
A Two-Case Report
Yong  Han  Yoon,  M.D.
1,  Jae  Ho  Kim,  M.D.
1,  Kwang  Ho  Kim,  M.D.
1,  Wan  Ki  Baek,  M.D.
1, 
Hyun  Kyu  Lee,  M.D.
2,  Moon  Hee  Lee,  M.D.
2,  Kyung  Hee  Lee,  M.D.
3,  Lucia  Kim,  M.D.
4
A large cell neuroendocrine carcinoma (LCNEC) of the thymus is a very rare malignant tumor that has a very 
poor prognosis. The detailed clinical features of LCNEC are still unknown, including the long term prognoses and 
the definitive modalities of the treatment for LCNEC of the thymus. We are reporting 2 cases of an enlarged 
LCNEC of the thymus, both of which were diagnosed and treated by surgical resection followed by postoperative 
adjuvant chemoradiation therapy. Although recurrences and metastases of the LCNEC were noticed 1 and 4 years 
postoperatively for each case, aggressive surgical resection and adjuvant chemoradiation therapy may be helpful for 
a patient’s long term survival.
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A 64-year-old male patient was admitted due to a 1 month 
history  of  cough  prior  to  admission.  He  had  been  relatively 
healthy except for hypertension for 10 years. He had smoked 
one  pack  of  cigarettes  every  day  for  30  years,  but  he  had 
s t o p p e d  s m o k i n g  5  y e a r s  p r i o r  to  admittance.  A  physical  ex-
amination revealed no specific findings. All laboratory results 
were within the normal limits including carcinoembryonic an-
tigen (CEA) levels. The chest posteroanterior (PA) radiograph 
(Fig.  1A)  showed  a  large  spherical  mass  obscuring  the  right 
heart  border.  A  chest  computed  tomography  (CT)  (Fig.  1B) 
revealed  a  soft  tissue  mass  in  the  right  anterior  mediastinum 
intertwined  with  the  mediastinal  fat.  No  fat  plane  was  ob-
served  separating  the  mass  from  the  ascending  aorta.  On 
transthoracic needle aspiration, the preoperative diagnosis was 
highly suspicious  for a  poorly differentiated carcinoma of the 
thymus.  The  preoperative  Masaoka  stage  was  stage  III.  A 
median sternotomy revealed that the mass (Fig. 2A) was well 
circumscribed,  lobulated,  grayish-yellow,  and  very  hard, 
measuring  8.5×6.5×6  cm  in  size.  The  mass  was  located  be-
tween the brachiocephalic vein and the diaphragm, and tightly 
adhered to the entire anterior pericardium, superior vena cava, 
ascending aorta, and the right upper lobe crossing the media-
stinal  pleura.  A  satellite  mass  2  cm  in  diameter  was  located 
left  of  the  brachiocephalic  vein.  The  masses  were  removed 
with  the  anterior  pericardium,  including  the  right  phrenic Giant LCNEC of the Thymus
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Fig. 2. (A) Gross findings of a 
large cell neuroendocrine carcinoma 
of case 1. The tumor is relatively 
well circumscribed and lobulated with 
a grayish-yellow, soft, solid, and gra-
nular cut surface. The tumor involves 
the adhered lung parenchyma and 
surrounding adipose tissue. Microsco-
pic findings of a large cell neuro-
endocrine carcinoma of case 1. (B) 
The tumor is composed of irregu-
larly-shaped solid nests with central 
necrosis (H&E, ×100). (C) The tumor 
cells show round nuclei, distinct nu-
cleoli, a low nuclear-to-cytoplasmic 
ratio, frequent mitotic figures, and a 
rosette-like structure (H&E, ×400).
(D) Some tumor cells are immunor-
eactive for the chromogranin immu-
nohistochemical stain (chromogranin, 
×200).
Fig. 1. (A) A chest radiograph of 
case 1 shows a large spherical mass 
obscuring the right heart border. (B) 
A chest computed tomography of 
case 1 reveals a soft tissue mass 
in the right anterior mediastinum in-
vading the mediastinal fat. No fat 
plane is seen separating the mass 
from the ascending aorta. 
nerve  and  lymph  nodes,  avoiding  injury  to  the  great  vessels. 
A  wedge  resection  of  the  right  upper  lobe  was  performed. 
The  final  pathological  report  showed  a  large  cell  neuro-
endocrine  carcinoma  (LCNEC)  o f  t h e  t h y m u s .  T h e  m i c r o -
scopic findings (Fig. 2B-D) showed the tumor was composed 
of irregularly-shaped solid nests with central necrosis. The tu-
mor  cells  showed  round  nuclei,  distinct  nucleoli,  a  low  nu-
clear-to-cytoplasmic  ratio,  frequent  mitotic  figures,  and  a  ro-
sette-like  structure.  The  tumor  cells  were  immunoreactive  for 
the neuroendocrine markers chromogranin, synaptophysin, and 
CD57  on  the  immunohistochemical  stains.  The  postoperative 
stage  was  Masaoka  stage  IVB  due  to  a  positive  anterior  me-Yong Han Yoon, et al
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Fig. 3. (A) Chest radiograph of case
2 shows a bilateral lobulated large 
mediastinal mass. (B) Contrast enha-
nced computed tomography of case 
2 shows a large anterior mediastinal 
mass with posterior displacement of 
the vascular structure. The mass en-
compasses the left internal mammary 
artery.
diastinal lymph node and invasion of tumor cells into the sur-
rounding  soft  tissue.  The  patient’s  postoperative  course  was 
complicated  due  to  a  mediastinal  infection  by  methicillin-re-
sistant  staphylococcus  aureus.  A  vacuum-assisted  closure  was 
applied  from  postoperative  day  21  to  36  and  then  the  sternal 
wound  was  closed  by  bilateral  pectoralis  major  muscle  rota-
t i o n  f l a p s .  H e  w a s  d i s c h a r g e d  o n  p o s t o p e r a t i v e  d a y  8 8 .  T h e  
postoperative  adjuvant  chemoradiation  therapy  was  postponed 
due  to  his  poor  general  condition  and  the  surgical  wound 
condition.  Radiation  therapy  was  attempted  with  4,500  cGy 
as  soon  as  he  developed  superior  vena  cava  syndrome  one 
year  later.  However,  metastases  to  the  liver  and  left  adrenal 
gland  had  been  found  6  months  after  radiation  therapy. 
Chemotherapy  was  attempted  12  times  using  a  cisplatin  60 
mg/m
2,  adriamycin  40  mg/m
2,  and  cyclophosphamide  750 
mg/m
2  regimen.  The  patient  is  still  alive  4  years  postsurgery 
although  multiple  metastases  were  noticed  in  his  liver,  in  the 
left  adrenal  gland,  and  in  the  bone  marrow.
2) Case 2
A  57-year-old  male  patient  was  admitted  due  to  a  known 
mediastinal  mass  that  had  been  discovered  by  coronary  com-
puted  tomography  6  months  before  this  admission  for  the 
evaluation of exertional chest pain. He had been hypertensive 
for  5  years  and  received  a  left  parotidectomy  due  to  Warth-
in’s  tumor  5  years  before  admission.  He  was  a  30-pack/year 
smoker, but he quit smoking 3 years prior to admittance. His 
physical examination was normal. His CEA level was normal. 
His chest PA (Fig. 3A) shows a bilateral lobulated large me-
diastinal mass. His chest CT (Fig. 3B) shows a large anterior 
mediastinal  mass  with  a  posterior  displacement  of  the  vas-
cular structure. The mass encompassed the left internal mam-
mary artery. A positron emission tomography scan showed no 
evidence of a distant metastasis. The mass was tentatively di-
agnosed  as  an  atypical  carcinoid  tumor  of  the  thymus  by  a 
transthoracic needle biopsy. Endeavoring to reduce the size of 
the  huge  mass,  preoperative  chemotherapy  was  attempted 
twice  with  an  100  mg/m
2  etoposide  and  60  mg/m
2  cisplatin 
which resulted in disease stabilization. The preoperative stage 
was  Masaoka  IVB.  Via  a  median  sternotomy,  a  17×12×6.5 
cm mass (Fig. 4A) was removed along with the anterior peri-
cardium  anterior  to  both  the  phrenic  nerves  6  weeks  later. 
The mass was hard, reddish, and H-shaped. It was tightly ad-
herent  to  the  superior  vena  cava,  ascending  aorta,  and 
pericardium.  The pathological  examination  of the  tumor mass 
(Fig.  4B,  C)  definitely  confirmed  an  LCNEC  of  the  thymus. 
The  tumor  cells  showed  large  nuclei  with  conspicuous  cyto-
plasm  and  distinct  nucleoli.  Neuroendocrine  features  such  as 
cribriform  and  trabeculae  were  observed.  Immunohistochem-
ical staining for neuroendocrine markers demonstrated a cyto-
plasmic  staining  pattern  in  the  tumor  cells.  The  anterior  me-
diastinal  nodes  were  positive  for  the  tumor  cells.  The  post-
operative Masaoka stage was IVB. The patient’s postoperative 
course  was  uneventful.  He  was  discharged  on  postoperative 
day  8.  Postoperative  radiation  therapy  was  started  with  6,000 
cGy  from  the  postoperative  day  45  at  the  outpatient  depart-
m e n t .  H e  i s  s t i l l  a l i v e  o n e  y e a r  a f t e r  t h e  s u r g e r y  b u t  m e t a -
stases were found in the left anterior chest wall and the third 
lumbar  vertebral  body. Giant LCNEC of the Thymus
− 63  −
Fig. 4. (A) The gross findings of the anterior mediastinal mass of case 2. The mass shows grayish-tan, fish-flesh, and soft cut surface 
with multifocal hemorrhagic and cystic areas. (B) The histologic findings of a large cell neuroendocrine carcinoma of case 2. show the tu-
mor cells have large nuclei with conspicuous cytoplasm and distinct nucleoli. Neuroendocrine features such as cribriform, cord, or trabeculae 
are visible (H&E, ×200). (C) Immunohistochemical staining for the neuroendocrine marker (synaptophysin) demonstrates diffuse cytoplasmic 
staining pattern in the tumor cells (synaptophysin, ×200).
DISCUSSION
A  LCNEC  of  the  thymus  is  a  very  rare  malignant  tumor 
which  has  a  very  poor  prognosis.  It  had  been  classified  as 
one variation of the carcinoid tumors of the thymus. The con-
c e p t  o f  L C N E C  w a s  f i r s t  i n t r o d u ced  by  Travis  et  al.  [1]  fol-
lowing  an  investigation  of  the  spectrum  of  pulmonary  neuro-
endocrine  carcinomas  that  had  been  traditionally  classified  as 
typical  carcinoids,  atypical  carcinoids,  or  small  cell  carcino-
m a s .  T h e  a u t h o r s  p r o p o s e d  a  f o u r t h  c a t e g o r y  o f  L C N E C  f o r  
the  higher  grade  non-small-cell  tumors.  They  had  charac-
t e r i z e d  L C N E C  b y  1 )  a  l i g h t  m i c roscopic  neuroendocrine  ap-
pearance,  2) large sized, polygonal-shaped  cells having  a low 
nuclear-cytoplasmic  ratio  with  coarse  nuclear  chromatin  and 
frequent  nucleoli,  3)  a  high  mitotic  rate  greater  than  10/10 
high  power  fields,  and  frequent  necrosis,  and  4)  neuroendoc-
rine  features  by  immunohistochemistry  or  electron  micro-
scopy.  As  such,  Moran  and  Suster  [2]  have  proposed  replac-
ing  the  term  thymic  carcinoid  with  thymic  neuroendocrine 
carcinoma  and  categorized  the  four  types  of  neuroendocrine 
carcinoma  according  to  the  histological  grade  and  different 
prognoses.  Both  typical  and  atypical  carcinoid  tumors  of  the 
thymus  may  express  neuroendocrine  markers  such  as  chro-
mogranin  A,  synaptophysin,  and  neuron-specific  enolase,  but 
LCNEC  and  small  cell  carcinoma  of  the  thymus  are  weakly 
or  rarely  positive  for  these  markers  [3].  However,  Chaer  et 
al. [4] reported that chromogranin is the most reliable marker 
of  neuroendocrine  carcinoma  of  the  thymus.  The  accurate  di-
a g n o s is  o f  a  t h y m i c  tu m o r  b y  a  s tandard  transthoracic  needle 
biopsy  is  challenging  due  to  the  morphologically  inhomoge-
neous  character  of  thymic  tumo r s .  A  t h o r a c o t o m y  m a y  o f f e r  
the  best  chance  for  a  definitive  diagnosis  and  treatment  for 
thymic  tumors  [5].  We  were  able  to  make  a  final  definitive 
diagnosis  of  LCNEC  of  the  thymus  and  confirmed  Masaoka 
stage  IVB  by  thoracotomies  in  our  two  cases.  There  is  still 
no  single  series  or  institute  of  study  for  these  tumors.  We 
w e r e  a b l e  t o  f i n d  s e v e r a l  c a s e  r e p o r t s  [ 3 ,  5 - 8 ]  i n  a  M e d l i n e  
search.  The  detailed  clinical  features  including  the  long-term 
prognosis  and  definitive  modalities  of  treatment  for  LCNEC 
of the thymus are still unknown. However, as with other thy-
mic  malignancies,  we  believe  that  complete  resection  of 
LCNEC  is  the  best  way  to  cure  the  disease.  Many  reports 
have shown an extremely poor long-term survival rate (patients 
usually died within 6 months after surgery) and frequent local 
recurrence and/or distant metastases after surgical resection of 
the  tumor  due  to  the  biologically  aggressive  behavior  of 
LCNEC  [3,5,6].  Cardillo  et  al.  [3]  reported  that  the  10-year 
survival  rate  was  100%  in  typical  carcinoid  patients  but  0% 
in  LCNEC  patients.  However,  Ogawa  et  al.  [7]  reported  a 
case  of  16  months  survival  after  surgical  resection  of  a Yong Han Yoon, et al
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Masaoka stage II LCNEC followed by adjuvant chemotherapy 
with Cisplatin and Irinotecan. Dutta et al. [8] reported a case 
of  LCNEC  with  sternal  invasion.  These  two  case  studies  re-
ported  a  complete  en  bloc  resection  with  postoperative  che-
moradiation  therapy,  which  may  be  beneficial  for  long-term 
survival and to prevent local recurrence and distant metastasis 
[7,8]. To obtain a definite diagnosis and to remove the mass-
es  putting  pressure  on  the  mediastinum,  we  had  performed 
radical resection, although incomplete, for our two cases, plus 
a  preoperative  chemotherapy  procedure  in  the  second  case, 
hoping  for  a  reduction  in  the  tumor  size  with  postoperative 
chemoradiation.  The  two  patients  have  been  alive  for  four 
years and one year to the present day, although they have lo-
cal  recurrences  and  distant  metastases.  We  believe  that  the 
aggressive therapy described in this report may be helpful for 
improving  the  quality  of  life,  delaying  local  recurrence,  and 
increasing  survival.
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